Skip to content
Trial Agents

Sjoegren'S Foundation

Sjoegren'S Foundation is recorded as a service provider in 6 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.

6distinct trials
6recorded service labels
0trials with learnings

Data snapshot: 2026-10-09 · About the data

Clinical trial experience

Showing 6 of 6 trials · Latest update first

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Telitacicept in Adult Participants with Active Primary Sjögren’s Disease

Sponsor Vor Biopharma Inc.

Start (EU)
Not reported
Latest update
Estimated end

A Phase 2, Randomized, Double-Blinded, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Efgartigimod PH20 Subcutaneous Administered by Prefilled Syringe in Adult Participants with Sjogren’s Disease-Associated Sensorimotor or Sensory Polyneuropathy

Sponsor Argenx

Start (EU)
Not reported
Latest update
Estimated end

A Phase 3 Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial with Open-Label Extension to Evaluate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 Subcutaneous Administered by Prefilled Syringe in Adult Patients with Primary Sjögren’s Disease

Sponsor Argenx

Start (EU)
Latest update
Estimated end

Questions about this trial experience

What services are recorded for Sjoegren'S Foundation?

The 2026-10-09 snapshot links Sjoegren'S Foundation to 6 distinct CTIS trials. Recorded services include Assessment Training, ESSDAI training for PI, ESSDAI training of investigators who assess ESSDAI in the study, Managing of ESSDAI training, among 6 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.

Which therapeutic areas and study phases are recorded for Sjoegren'S Foundation?

The most frequently recorded therapeutic areas are Immunology, Rheumatology, Neurology. Recorded phases include Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.

In which countries are trials linked to Sjoegren'S Foundation conducted?

The linked trials record locations in 19 countries, including Germany, Spain, Poland, Bulgaria, France. These are trial locations, not confirmed office locations or countries where Sjoegren'S Foundation delivered services.

What can this page tell me about Sjoegren'S Foundation's trial experience?

Browse 6 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.

About this data & company names

One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.

Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.

Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Sjoegren'S Foundation. Legacy brands remain separate unless explicitly matched in the name registry.

View recorded company names
  • Sjoegren'S Foundation Inc.

Never miss a new clinical trial insight

We continuously analyze new and updated clinical trial data and publish practical, evidence-led reports for clinical leaders.